Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis - Wikidata - wikimedia - TriplyDB

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

http://www.wikidata.org/entity/Q28303406

about

CX3CR1 is a modifying gene of survival and progression in amyotrophic lateral sclerosis Sporadic ALS is not associated with VAPB gene mutations in Southern Italy Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice Treatment for familial amyotrophic lateral sclerosis/motor neuron disease Treatment for familial amyotrophic lateral sclerosis/motor neuron disease Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis From animal models to human disease: a genetic approach for personalized medicine in ALS Transcriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson's disease Risk factors for amyotrophic lateral sclerosis State of play in amyotrophic lateral sclerosis genetics Human neural stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantation Crystal structure of Cu / Zn superoxide dismutase from Taenia solium reveals metal-mediated self-assembly The role of insulin/IGF-1 signaling in the longevity of model invertebrates, C. elegans and D. melanogaster The complex molecular biology of amyotrophic lateral sclerosis (ALS)Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis What causes amyotrophic lateral sclerosis?Structural and functional analysis of human SOD1 in amyotrophic lateral sclerosis.Human embryonic stem cell-derived motor neurons expressing SOD1 mutants exhibit typical signs of motor neuron degeneration linked to ALS.Lipid-associated aggregate formation of superoxide dismutase-1 is initiated by membrane-targeting loops.Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays.A 14-3-3 mRNA is up-regulated in amyotrophic lateral sclerosis spinal cord.Expression of AMPA and NMDA receptor subunits in the cervical spinal cord of wobbler mice Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival.Metal-free ALS variants of dimeric human Cu,Zn-superoxide dismutase have enhanced populations of monomeric species Effect of genetic background on the phenotype of the Smn2B/- mouse model of spinal muscular atrophy.Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis.Finding inhibitors of mutant superoxide dismutase-1 for amyotrophic lateral sclerosis therapy from traditional chinese medicine.Complex genetics of amyotrophic lateral sclerosis.Peripheral hyperstimulation alters site of disease onset and course in SOD1 rats NEDL1, a novel ubiquitin-protein isopeptide ligase for dishevelled-1, targets mutant superoxide dismutase-1.Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study.Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: decreased stability of the apo state.Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis.Drosophila orthologue of WWOX, the chromosomal fragile site FRA16D tumour suppressor gene, functions in aerobic metabolism and regulates reactive oxygen species.Familial amyotrophic lateral sclerosis.Identification of human monoclonal antibodies specific for human SOD1 recognizing distinct epitopes and forms of SOD1.Antisense oligonucleotide therapy for neurodegenerative disease.Programmed cell death in amyotrophic lateral sclerosis High-Resolution Melting (HRM) Analysis of the Cu/Zn Superoxide Dismutase (SOD1) Gene in Japanese Sporadic Amyotrophic Lateral Sclerosis (SALS) Patients.Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats.

P2860

Q21132045-E912E48B-0FFE-4D63-9544-1D96BF7E8FED Q21245641-106587D8-CBD2-451A-A6F9-85614D5E4790 Q21560962-6FF899E3-076D-4851-98AF-6EF1C3D47A88 Q24241570-5AC6CF63-5C7D-4651-BFEC-61F28EBBFA53 Q24245711-4E9F1D15-4494-440A-BD1F-AE38B78F38F1 Q24630353-45D5138C-6D40-426C-BA99-E8069A7579B7 Q26741250-C7B2A84E-909F-4F99-B868-98AF636CC492 Q26796502-8587453A-A567-4A5E-8B1D-7C13B47B5BB6 Q26827642-452B47FD-95C6-46A0-AA3A-87630EFF1CC2 Q26864816-6035C438-20D5-4992-BCA5-14F2BA14C834 Q27324779-8A5DA9DE-0534-4788-8767-4436D66C4315 Q27670860-DB6FE8C1-8304-481D-8FD4-4DB436A506DC Q28083445-ADBA7A31-88C3-4997-AE51-279FDF8A4EAC Q28263899-D61FC362-62D5-4FCB-9DF4-F7CD225EDD0D Q28943310-D159F94E-D4F3-4FE4-83E9-04FF1AAC11D7 Q30234813-F399A979-5BF7-4452-83AD-CA32A58E89B9 Q30356499-0C734631-0551-4B9F-997A-057C329F0162 Q30486275-B6187E95-5D41-4947-A54A-7290759FF33F Q30850744-759A65A2-F3F1-4956-9C4B-9D787D73632E Q30865041-E0863AF3-66C1-407B-8E41-6BD8725418E7 Q30962866-0427CE27-2D0C-4711-9F48-9579293EE2D6 Q33261656-43BF1535-9FCE-4557-ACD4-32C3436BEFFC Q33356197-A8334496-BE1A-4297-B454-C79870779E03 Q33559671-63612A58-DC41-4E3C-8824-66DFA805655A Q33615182-0795C0F5-EC17-42DE-BD09-5A15A910A513 Q33687938-C586AA4A-7058-4FD4-9426-92DCD61F6086 Q33736326-73EA46DE-6D40-4FE7-B089-F333D77BB35C Q33910597-86869B40-FD70-40C2-99EE-E8458E077FAB Q34020539-53957DC7-35A6-4705-B83C-9A169EAAA37F Q34284915-BD49A41A-882F-4375-82BA-499F8B1CC68D Q34340508-AF584AAC-6B79-4AE1-81A0-610F4F8A583E Q34429205-97744A0C-CCEE-4EAC-8600-B0ACAAE0D937 Q34455748-A4D030F8-792D-4E66-9BA5-CD27A45A4995 Q34470652-56CE02D0-B652-4BC4-A286-8A31A388887A Q34547620-B44A77C1-1356-40FF-BA58-2A762B246255 Q34684165-9A1883E8-F5D9-4BEC-82AB-BBD413FBA738 Q34830633-013BB2DA-C6AA-45F2-80DA-1EA5A5EA7A2D Q34831541-3D780130-2660-4AA9-B435-960A859EC374 Q34986465-495A4DB3-1620-431C-B94E-AF8286740EA6 Q34994432-8C111BDC-318B-46A1-9D9C-B6C3B08C896F

P2860

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

http://www.wikidata.org/entity/Q28303406

description

1997 nî lūn-bûn

@nan

1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

@ast

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

@en

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

@nl

type

label

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

@ast

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

@en

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

@nl

prefLabel

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

@ast

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

@en

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

@nl

P1433

Q28303406-ACB9CC12-BD16-4A4B-8BEC-55C4D7E49E63

P1476

Q28303406-76BBE16A-1F38-40B3-A0EF-4B022F45F0B7

P2093

Q28303406-02762908-948B-494F-AFDF-8389592701D5

Q28303406-03AF41FF-6273-4B97-8276-2CC92BF4FBBC

Q28303406-352966BC-EB97-4387-88CA-C2934263995B

Q28303406-4357CDAB-2BED-4AFD-8863-B2D8865FEDC3

Q28303406-63A6A544-C289-4782-BD20-2FC1E4C3D097

Q28303406-666809F3-19D6-4870-9ECB-9A681957E45C

Q28303406-C8E6CDAE-B8B0-44E1-9BDD-0DEB1BF87B39

Q28303406-CA8C74D2-A247-4A25-A709-797509833ECC

Q28303406-D554A966-C814-41CA-B11C-3D54DC2565D6

P304

Q28303406-7856F870-FB90-4BE5-9E5F-64F01F454DA8

P31

Q28303406-71B1F891-A7A0-4D11-BB58-AA425CCD7D91

P3181

Q28303406-48CD3ADF-6D78-4716-8548-59E9164CC593

P356

Q28303406-2BDC2C2C-82DA-426D-9ACF-30D7DB5B87D9

P407

Q28303406-DCA81FF2-419D-4E52-B53F-6A1A9BA5D806

P433

Q28303406-23811FF9-FAA7-4969-95A5-537C00BF0732

P478

Q28303406-7EB2EC34-94F3-412C-86EA-4F97F0CEFEAC

P50

Q28303406-619FB821-1666-4A56-AEB4-8E81197321FB

P577

Q28303406-13FEEA90-DBA2-492B-A218-51BFC902C0E6

P698

Q28303406-AC724203-DAD3-4B61-8EEC-1D5167161F47

P921

Q28303406-49B03AC1-B323-4D22-B611-61B87E4EE28B

Q28303406-72092275-D5A7-4E91-B119-F6A2FB92A84C

P3181

P356

P1433

Annals of Neurology

P1476

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

@en

P2093

B A Hosler

http://www.w3.org/2001/XMLSchema#string

B Geller

http://www.w3.org/2001/XMLSchema#string

D A Schoenfeld

http://www.w3.org/2001/XMLSchema#string

D L Hayden

http://www.w3.org/2001/XMLSchema#string

D McKenna-Yasek

http://www.w3.org/2001/XMLSchema#string

M E Cudkowicz

http://www.w3.org/2001/XMLSchema#string

P E Sapp

http://www.w3.org/2001/XMLSchema#string

R H Brown

http://www.w3.org/2001/XMLSchema#string

W Chin

http://www.w3.org/2001/XMLSchema#string

P304

210-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

144033

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/ANA.410410212

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P50

H. Robert Horvitz

P577

1997-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9029070

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis